about
The Subcellular Dynamics of the Gs-Linked Receptor GPR3 Contribute to the Local Activation of PKA in Cerebellar Granular NeuronsThe Gs-linked receptor GPR3 maintains meiotic arrest in mammalian oocytesThe Development of Screening Methods to Identify Drugs to Limit ER Stress Using Wild-type and Mutant Serotonin TransporterEffect of trehalose on the properties of mutant {gamma}PKC, which causes spinocerebellar ataxia type 14, in neuronal cell lines and cultured Purkinje cells.The Gs-linked receptor GPR3 inhibits the proliferation of cerebellar granule cells during postnatal developmentEstablishment of a novel fluorescence-based method to evaluate chaperone-mediated autophagy in a single neuron.Regulation of meiotic prophase arrest in mouse oocytes by GPR3, a constitutive activator of the Gs G proteinA brain-specific Grb2-associated regulator of extracellular signal-regulated kinase (Erk)/mitogen-activated protein kinase (MAPK) (GAREM) subtype, GAREM2, contributes to neurite outgrowth of neuroblastoma cells by regulating Erk signalingDeregulation of the actin cytoskeleton and macropinocytosis in response to phorbol ester by the mutant protein kinase C gamma that causes spinocerebellar ataxia type 14.Mutant γPKC that causes spinocerebellar ataxia type 14 upregulates Hsp70, which protects cells from the mutant's cytotoxicity.Mutant protein kinase C gamma that causes spinocerebellar ataxia type 14 (SCA14) is selectively degraded by autophagy.Adenovirus-mediated gene transfer of heparin-binding epidermal growth factor-like growth factor enhances neurogenesis and angiogenesis after focal cerebral ischemia in rats.Purification of a trypsin-type protease from human umbilical vein endothelial cells which is highly sensitive to the Kunitz inhibitor domain peptide of Alzheimer's disease amyloid protein precursor.Developmental expression of GPR3 in rodent cerebellar granule neurons is associated with cell survival and protects neurons from various apoptotic stimuli.Induction of the HSP110/105 family in the rat hippocampus in cerebral ischemia and ischemic tolerance.Protective effect of apolipoprotein E against ischemic neuronal injury is mediated through antioxidant action.Implication of cyclooxygenase-2 on enhanced proliferation of neural progenitor cells in the adult mouse hippocampus after ischemia.Antibody against the carboxyl terminus of the F2 subunit of Sendai virus fusion glycoprotein inhibits proteolytic activation.Effects of the chemical chaperone 4-phenylbutylate on the function of the serotonin transporter (SERT) expressed in COS-7 cells.The Role of Cysteine String Protein α Phosphorylation at Serine 10 and 34 by Protein Kinase Cγ for Presynaptic Maintenance.Modifications of tau protein after cerebral ischemia and reperfusion in rats are similar to those occurring in Alzheimer's disease - Hyperphosphorylation and cleavage of 4- and 3-repeat tau.Hypoxic stress activates chaperone-mediated autophagy and modulates neuronal cell survival.Validation of Anti-CSPα, SNAP25, Tyrosine Hydroxylase, Ubiquitin, Cleaved Caspase 3, and pSer PKC Motif Antibodies for Utilization in Western Blotting.Extracellular ATP differentially modulates Toll-like receptor 4-mediated cell survival and death of microglia.Propofol induced diverse and subtype-specific translocation of PKC families.CRE-mediated gene transcription in the peri-infarct area after focal cerebral ischemia in miceSKF-10047, a prototype Sigma-1 receptor agonist, augmented the membrane trafficking and uptake activity of the serotonin transporter and its C-terminus-deleted mutant via a Sigma-1 receptor-independent mechanismSpinocerebellar ataxia type 14 caused by a nonsense mutation in the PRKCG gene
P50
Q27326217-CA25062F-0670-4F74-866A-0B1A8941D7B7Q28505809-39369D17-5539-43A6-BEF0-A1CB3FC04D2BQ28818314-57BDA9B4-1D21-482D-AC1F-F7DDC2E543BDQ30497111-44F13F12-47AE-46E7-9E24-6E16A073043EQ33467402-89D62094-5A56-40B6-8D4F-5CF18D2D7F2FQ34170664-16F41AD3-2871-4691-A862-0523F661DD67Q36320295-2DDE73E7-E872-47C6-A974-A4BA900FDCEAQ37226266-F32269A9-F17F-4B89-ABEF-1D9B44E129D4Q38642817-FA18BA7A-EFF4-4F67-9B88-D855E5DD96D6Q39097836-DAF71F3A-78CC-45B9-A62F-44B861082C67Q39714056-B0E307CD-EC73-4A7A-A4B1-7EB5943C093FQ40450828-D77758E7-24C3-48AE-BF0C-B0879E3A99B4Q41583672-707F9F8C-984E-4325-8969-FE619BD24AE5Q42458017-7D9A61A6-94DF-4DF9-8857-8210E84D9F8AQ43660771-B0C697B6-ABFE-4764-8297-17105F022D56Q43956277-3A7A7C87-547C-4F37-88C1-F3DB31D7B3B3Q44409694-EC86A124-9D72-40CB-901F-9367872A9A0BQ45775226-901C0C1B-99B2-49C8-96A6-79410911FBC1Q45863490-13113686-E84B-4B77-BBB6-8D3BCE65A090Q47372346-8DA98D69-D7DC-45CE-95EE-61E97C520272Q48513312-E297AAAF-9541-447A-848B-3C2E9BDDC683Q48673421-24E9D9AC-1398-4313-8BC4-C649CA830D55Q49473889-335A6CC9-5AA6-4594-8BA6-B460F36FED42Q50438980-8C8A97CF-23E1-40D7-AC64-B80CA76222BEQ54114087-ADE6FDD0-3A11-46F5-85F3-E161792A057FQ75332680-198289A4-6AE6-4C12-802F-58FBC2CDC3FBQ90315503-BF80861B-0D9B-47F5-BD75-5560C49C288FQ92489614-46C1B79E-4F15-43F4-B7FC-B4D8C46F2AFF
P50
description
Forscher
@de
Japanese neuroscientist
@en
investigador
@es
onderzoeker
@nl
ricercatore
@it
研究員
@ja
研究者
@zh
name
Shigeru Tanaka
@en
Tanaka S
@ast
Tanaka S
@nl
type
label
Shigeru Tanaka
@en
Tanaka S
@ast
Tanaka S
@nl
prefLabel
Shigeru Tanaka
@en
Tanaka S
@ast
Tanaka S
@nl
P106
P31
P496
0000-0003-3247-9098